(GAIN) Gladstone Investment - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US3765461070
Stock: Debt, Equity, Lending, Investments
Total Rating 34
Risk 69
Buy Signal 0.00
| Risk 5d forecast | |
|---|---|
| Volatility | 18.2% |
| Relative Tail Risk | -5.23% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.70 |
| Alpha | 6.49 |
| Character TTM | |
|---|---|
| Beta | 0.494 |
| Beta Downside | 0.828 |
| Drawdowns 3y | |
|---|---|
| Max DD | 14.76% |
| CAGR/Max DD | 1.22 |
EPS (Earnings per Share)
Revenue
Description: GAIN Gladstone Investment March 05, 2026
Gladstone Investment Corporation (GAIN) operates as a business development company (BDC), a structure mandated to distribute at least 90% of its taxable income to shareholders. It focuses on the lower middle market in the United States.
GAINs investment strategy targets mature-stage buyouts and debt refinancing. It deploys capital through various debt instruments, including senior, senior subordinated, and junior subordinated debt, alongside equity investments. BDCs primarily provide capital to small and mid-sized companies.
The company seeks opportunities in manufacturing, consumer products, and business/consumer services sectors. It targets companies with specific EBITDA ranges and prefers minority equity ownership, often securing a board seat. It may also take majority stakes.
GAIN typically holds investments for seven years, exiting through sales, recapitalizations, or IPOs. For more detailed financial analysis, consider exploring ValueRay.
Headlines to watch out for
- Interest rate fluctuations impact debt investment income
- Lower middle market M&A activity drives investment exits
- Portfolio company performance affects dividend distributions
- Regulatory changes for BDCs create operational risks
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 130.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.07 > 0.02 and ΔFCF/TA -16.86 > 1.0 |
| NWC/Revenue: -54.75% < 20% (prev -20.77%; Δ -33.98% < -1%) |
| CFO/TA -0.07 > 3% & CFO -81.8m > Net Income 130.4m |
| Net Debt (570.5m) to EBITDA (57.9m): 9.84 < 3 |
| Current Ratio: 0.09 > 1.5 & < 3 |
| Outstanding Shares: last quarter (39.7m) vs 12m ago 8.03% < -2% |
| Gross Margin: 71.60% > 18% (prev 0.72%; Δ 7.09k% > 0.5%) |
| Asset Turnover: 10.70% > 50% (prev 10.65%; Δ 0.06% > 0%) |
| Interest Coverage Ratio: -1.58 > 6 (EBITDA TTM 57.9m / Interest Expense TTM 36.6m) |
Altman Z'' -0.23
| A: -0.05 (Total Current Assets 6.19m - Total Current Liabilities 67.9m) / Total Assets 1.24b |
| B: 0.09 (Retained Earnings 108.7m / Total Assets 1.24b) |
| C: -0.06 (EBIT TTM -58.0m / Avg Total Assets 1.05b) |
| D: 0.17 (Book Value of Equity 108.7m / Total Liabilities 641.2m) |
| Altman-Z'' Score: -0.23 = B |
Beneish M
| DSRI: 0.42 (Receivables 4.84m/9.46m, Revenue 112.7m/92.5m) |
| GMI: 1.01 (GM 71.60% / 72.12%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.22 (Revenue 112.7m / 92.5m) |
| TATA: 0.17 (NI 130.4m - CFO -81.8m) / TA 1.24b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of GAIN shares?
As of March 20, 2026, the stock is trading at USD 14.42 with a total of 422,247 shares traded.
Over the past week, the price has changed by +2.63%, over one month by +4.57%, over three months by +5.71% and over the past year by +18.03%.
Over the past week, the price has changed by +2.63%, over one month by +4.57%, over three months by +5.71% and over the past year by +18.03%.
Is GAIN a buy, sell or hold?
Gladstone Investment has received a consensus analysts rating of 4.20.
Therefore, it is recommended to buy GAIN.
- StrongBuy: 3
- Buy: 0
- Hold: 2
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the GAIN price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 14.8 | 2.8% |
| Analysts Target Price | 14.8 | 2.8% |
GAIN Fundamental Data Overview March 16, 2026
P/E Trailing = 4.4367
P/E Forward = 14.771
P/S = 5.5042
P/B = 0.9384
P/EG = 5.4094
Revenue TTM = 112.7m USD
EBIT TTM = -58.0m USD
EBITDA TTM = 57.9m USD
Long Term Debt = 129.0m USD (estimated: total debt 571.8m - short term 442.9m)
Short Term Debt = 442.9m USD (from shortTermDebt, last quarter)
Debt = 571.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 570.5m USD (from netDebt column, last quarter)
Enterprise Value = 1.13b USD (558.3m + Debt 571.8m - CCE 1.38m)
Interest Coverage Ratio = -1.58 (Ebit TTM -58.0m / Interest Expense TTM 36.6m)
EV/FCF = -13.80x (Enterprise Value 1.13b / FCF TTM -81.8m)
FCF Yield = -7.25% (FCF TTM -81.8m / Enterprise Value 1.13b)
FCF Margin = -72.63% (FCF TTM -81.8m / Revenue TTM 112.7m)
Net Margin = 115.7% (Net Income TTM 130.4m / Revenue TTM 112.7m)
Gross Margin = 71.60% ((Revenue TTM 112.7m - Cost of Revenue TTM 32.0m) / Revenue TTM)
Gross Margin QoQ = 82.44% (prev 73.33%)
Tobins Q-Ratio = 0.91 (Enterprise Value 1.13b / Total Assets 1.24b)
Interest Expense / Debt = 1.66% (Interest Expense 9.49m / Debt 571.8m)
Taxrate = 21.0% (US default 21%)
NOPAT = -45.8m (EBIT -58.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.09 (Total Current Assets 6.19m / Total Current Liabilities 67.9m)
Debt / Equity = 0.96 (Debt 571.8m / totalStockholderEquity, last quarter 595.4m)
Debt / EBITDA = 9.84 (Net Debt 570.5m / EBITDA 57.9m)
Debt / FCF = -6.97 (negative FCF - burning cash) (Net Debt 570.5m / FCF TTM -81.8m)
Total Stockholder Equity = 527.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.38% (Net Income 130.4m / Total Assets 1.24b)
RoE = 24.70% (Net Income TTM 130.4m / Total Stockholder Equity 527.8m)
RoCE = -8.83% (EBIT -58.0m / Capital Employed (Equity 527.8m + L.T.Debt 129.0m))
RoIC = -4.35% (negative operating profit) (NOPAT -45.8m / Invested Capital 1.05b)
WACC = 4.48% (E(558.3m)/V(1.13b) * Re(7.73%) + D(571.8m)/V(1.13b) * Rd(1.66%) * (1-Tc(0.21)))
Discount Rate = 7.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 7.47%
[DCF] Fair Price = unknown (Cash Flow -81.8m)
EPS Correlation: -49.58 | EPS CAGR: -52.26% | SUE: -3.33 | # QB: 0
Revenue Correlation: 17.05 | Revenue CAGR: 6.62% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.22 | Chg7d=+0.003 | Chg30d=-0.006 | Revisions Net=+0 | Analysts=4
EPS next Year (2027-03-31): EPS=0.88 | Chg7d=-0.007 | Chg30d=-0.040 | Revisions Net=+0 | Growth EPS=+117.3% | Growth Revenue=+7.5%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -14.6% (Discount Rate 7.9% - Earnings Yield 22.5%)
[Growth] Growth Spread = +25.7% (Analyst 11.1% - Implied -14.6%)
P/E Forward = 14.771
P/S = 5.5042
P/B = 0.9384
P/EG = 5.4094
Revenue TTM = 112.7m USD
EBIT TTM = -58.0m USD
EBITDA TTM = 57.9m USD
Long Term Debt = 129.0m USD (estimated: total debt 571.8m - short term 442.9m)
Short Term Debt = 442.9m USD (from shortTermDebt, last quarter)
Debt = 571.8m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 570.5m USD (from netDebt column, last quarter)
Enterprise Value = 1.13b USD (558.3m + Debt 571.8m - CCE 1.38m)
Interest Coverage Ratio = -1.58 (Ebit TTM -58.0m / Interest Expense TTM 36.6m)
EV/FCF = -13.80x (Enterprise Value 1.13b / FCF TTM -81.8m)
FCF Yield = -7.25% (FCF TTM -81.8m / Enterprise Value 1.13b)
FCF Margin = -72.63% (FCF TTM -81.8m / Revenue TTM 112.7m)
Net Margin = 115.7% (Net Income TTM 130.4m / Revenue TTM 112.7m)
Gross Margin = 71.60% ((Revenue TTM 112.7m - Cost of Revenue TTM 32.0m) / Revenue TTM)
Gross Margin QoQ = 82.44% (prev 73.33%)
Tobins Q-Ratio = 0.91 (Enterprise Value 1.13b / Total Assets 1.24b)
Interest Expense / Debt = 1.66% (Interest Expense 9.49m / Debt 571.8m)
Taxrate = 21.0% (US default 21%)
NOPAT = -45.8m (EBIT -58.0m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 0.09 (Total Current Assets 6.19m / Total Current Liabilities 67.9m)
Debt / Equity = 0.96 (Debt 571.8m / totalStockholderEquity, last quarter 595.4m)
Debt / EBITDA = 9.84 (Net Debt 570.5m / EBITDA 57.9m)
Debt / FCF = -6.97 (negative FCF - burning cash) (Net Debt 570.5m / FCF TTM -81.8m)
Total Stockholder Equity = 527.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.38% (Net Income 130.4m / Total Assets 1.24b)
RoE = 24.70% (Net Income TTM 130.4m / Total Stockholder Equity 527.8m)
RoCE = -8.83% (EBIT -58.0m / Capital Employed (Equity 527.8m + L.T.Debt 129.0m))
RoIC = -4.35% (negative operating profit) (NOPAT -45.8m / Invested Capital 1.05b)
WACC = 4.48% (E(558.3m)/V(1.13b) * Re(7.73%) + D(571.8m)/V(1.13b) * Rd(1.66%) * (1-Tc(0.21)))
Discount Rate = 7.73% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 100.0 | Cagr: 7.47%
[DCF] Fair Price = unknown (Cash Flow -81.8m)
EPS Correlation: -49.58 | EPS CAGR: -52.26% | SUE: -3.33 | # QB: 0
Revenue Correlation: 17.05 | Revenue CAGR: 6.62% | SUE: -0.04 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.22 | Chg7d=+0.003 | Chg30d=-0.006 | Revisions Net=+0 | Analysts=4
EPS next Year (2027-03-31): EPS=0.88 | Chg7d=-0.007 | Chg30d=-0.040 | Revisions Net=+0 | Growth EPS=+117.3% | Growth Revenue=+7.5%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = -14.6% (Discount Rate 7.9% - Earnings Yield 22.5%)
[Growth] Growth Spread = +25.7% (Analyst 11.1% - Implied -14.6%)